About
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026
Feb 25 2026
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook
Feb 18 2026
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
Jan 2 2026
Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance
Nov 10 2025
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
Financials
Revenue
$296.15 M
Market Cap
$577.23 M
P/E Ratio
23.60
EPS
0.15
Translate